An exciting journey for Process Engineers to join Diamyd Medical’s own biologic manufacturing facility in Umeå.
Diamyd Medical is expanding by recruiting Upstream Process Engineers. Diamyd Medical develops precision medicine therapies for Type 1 Diabetes. The lead product, Diamyd®, is an antigen-specific immunotherapy for the preservation of endogenous insulin production. The company’s confirmatory Phase III trial, DIAGNODE-3, is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the US.
The company has established a new biologics manufacturing site in Umeå for the manufacture of rhGAD65, the active pharmaceutical ingredient in Diamyd®, and the development of future assets.
Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.
You will work in cross-functional teams to ensure seamless integration between upstream and downstream processes and you will report to the COO Manufacturing Site. Due to the nature of the job, work outside office hours will occur.
Key responsibilities :
Relevant background and experience :
Welcome to apply via haegercarlsson.com
Questions are answered by :
Lena Sörskog 070-692 45 70, [email protected]
Anna Wikman 073-539 33 87, [email protected]